Allopurinol
- Product NDC
- 53002-4820
- 11-digit product format
- 530024820
- Labeler code
- 53002
- Product ID
- 53002-4820_d0187247-fb0d-4ee0-b70c-b47a23750ca6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Allopurinol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA071450
- Marketing category
- ANDA
- Marketing start
- 1987-01-09
- Marketing end
- 0000-00-00
- Substance
- ALLOPURINOL
- Active strength
- 300 mg/1
- Pharmacologic classes
- Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-4820-0 | Allopurinol | 100 in 1 BOTTLE | TABLET | 100 | | 5 |
| 53002-4820-3 | Allopurinol | 30 in 1 BOTTLE | TABLET | 30 | | 5 |
| 53002-4820-6 | Allopurinol | 60 in 1 BOTTLE | TABLET | 60 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-4820 | ALLOPURINOL TABLET [RPK PHARMACEUTICALS, INC.] | 5 | Legacy NDC, 3 package rows | 20230609_7e6fbb4b-06fb-4405-b170-db905836a0e3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-4820-0 | 53002482000 | 100 TABLET in 1 BOTTLE (53002-4820-0) | 100 tablet | 2018-10-01 | 0000-00-00 | No | No | Current |
| 53002-4820-3 | 53002482003 | 30 TABLET in 1 BOTTLE (53002-4820-3) | 30 tablet | 2018-10-01 | 0000-00-00 | No | No | Current |
| 53002-4820-6 | 53002482006 | 60 TABLET in 1 BOTTLE (53002-4820-6) | 60 tablet | 2018-10-01 | 0000-00-00 | No | No | Current |